Investment and support for the next generation of artificial intelligence founders

Venture builder for independent gaming, mixed reality and digital media startups

Led the product development and customer acquisition strategy of a medical software startupSold the company to Natus Medical

Closed £5bn of M&A deals in a wide variety of industries across the UK and Europe specialising in complex financing structures requiring debt, equity and hybrid financeLed cross-functional teams bringing together legal, compliance, industry experts and market syndication teams to structure public and private transactions

Managed ING’s portfolio of private equity and venture capital assets:- Buy. Evaluated and bought investments in primary and secondary structured acquisition equity and debt instruments- Sell. Modelled portfolio company outlook and sold when lucrative opportunities exits presented themselves- Hold. Valued portfolio assets and accumulated further positions when secondary market prices fell below assessed worth

Winner of IFR "Leveraged Finance House of the Year"Closed a wide variety of private equity deals across industry sectors and geographies in Europe: - ₤300m Warburg Pincus buyout of Europe’s number 1 manufacturer of specialty survival equipment - €1500m CVC buyout of CEE’s number 1 beer brewing and distribution business (EuroWeek Leveraged Deal of the Year 2009) - ₤340m Arcapita buyout of the UK’s number 2 deep sea and heavy haul rail freight operator - €790m Doughty Hanson buyout of a leading global provider of accountancy services - €860m MLPE buyout of Europe and CEE’s number 1 dialysis and diagnostics healthcare provider - ₤580m Warburg Pincus buyout of Europe’s number 1 industrial solvent service provider and distributor

Managed the company spin out strategy for a £12m program to commercialise research from the University of Oxford’s Institute of Biomedical Engineering

Developed engineering and geological models to characterise the physics and optimise engineering processes in the extraction of oil and gas fields

Built models to characterise and predict the chemistry and physical properties of novel hydrogel materials developed by the companyDeveloped and scaled industrial processes for the production of proprietary medical-grade polymer materials in an industrial manufacturing line